In one paragraphArticle in Physics in medicine and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Mislav BobićDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.ORCID 0000-0002-9409-8680 Carlos Huesa-BerralDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.ORCID 0000-0003-2290-0176 Jack F TerryDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.
Louis KunzDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.ORCID 0009-0008-6526-6025 Jan SchuemannDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.ORCID 0000-0002-7554-8818 Darrell R FisherVersant Medical Physics and Radiation Safety, Richland, Washington, and University of Washington, Seattle, United States of America.
Charles A MaitzDepartment of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, United States of America.ORCID 0000-0003-2075-3926 Alejandro BertoletDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.ORCID 0000-0002-9890-693X Funding
TOPAS - nBio, a Monte Carlo tool for radiation biology researchR01CA187003 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SCHUEMANN, JAN PATRICK OSCAR · 2015 to 2024
$4.8MRadiation dosimetry for alpha-particle radiopharmaceutical therapy and application to pediatric neuroblastomaR00CA267560 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BERTOLET REINA, ALEJANDRO · 2023 to 2025
$721kNCI NIH HHS R00 CA267560NCI NIH HHS R01 CA187003
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Monte Carlo MethodRadiometryAnimalsDogsPhantoms, ImagingPositron Emission Tomography Computed TomographyRadiotherapy DosageSarcomaYttrium RadioisotopesYttrium-90Yttrium Radioisotopescomparative oncologydog cancer modelsdosimetryIsoPetRadioGelsoft tissue sarcomasY-90 therapy
Identifiers
PMID39053508
PMCPMC11583174
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390